PMCL - reschedules LIVE interactive boardroom conference

Houston Texas, February 09, 2007 –- Pharm Control Ltd. (Pinksheets: PMCL) are rescheduling their appearance on the Qwoter Boardroom do to an extended stay in Germany and Poland to oversee the launch of their products in those countries.

Pharm Control Ltd. tentatively reschedules their live boardroom conference to 10:30 a.m. Central Standard Time this Wednesday, February 14, 2007.

Interested parties may go to www.qwoter.com and signup and login to the "FREE" audio and video boardroom enabling them to listen and interact with management's review of operations and discussion of future prospects.

This live broadcast is available to anyone at any computer connected to the internet. The company apologizes for any inconvenience this may have caused, this should prove to be an eye-opening and enriching experience for all of those investors / prospective investors associated with Pharm Control Ltd. (Pinksheets: PMCL).

If you would like to sign-up and interact with Pharm Control Ltd. (Pinksheets: PMCL) management please go to http://www.qwoter.com/boardroom, scheduled to appear is the companys IR agent Mr. Krone.

About Pharm Control Ltd. (Pinksheets: PMCL):

Pharm Control Ltd. (Pinksheet: PMCL) of Canada is a leading All Natural and Oriental medicine research and development company, which is devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. Its founders have invested over 10 years of research discovering and developing new and effective non-synthetic medicines to fight disorders and sickness in modern world.

Pharm Control Ltd. is devoted to discovering and developing new medicines that will enable patients to live longer, healthier and more productive lives.

Pharm Control Ltd. mission is to develop natural and no side effect supplement to cure diseases such as Diabetes, High Blood and high Cholesterol related sickness, Digestive Disorders, Liver and Kidney diseases.

Pharm Control Ltd. believes that balance of the human body system can cure any type of diseases naturally.

Safe Harbor Statement
 
The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words "may," "will," "should," "plans," "explores," "expects," "anticipates," "continue," "estimate," "project," "intend," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technological advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, and various other factors beyond the Company's control.

Qwoter Website
http://www.qwoter.com

Qwoter PMCL Profile
http://www.qwoter.com/profiles/item.php?id=34&dir=1

Pharm Control Ltd. Website:
Web site: http://www.control24.114toronto.com

About Qwoter.com and Qwoter Boardroom Conferences

Qwoter.com is an online micro cap news provider / aggregator which brings investors current up to date news on the micro cap markets. Qwoter.com provides feeds from online live radio and video web sites that bring real micro cap news to investors and features live interaction with companies from the Bulletin Board, Pink Sheets, and Amex.

Qwoter Issuer Services provides microcap issuers the ability to use services offered by Qwoter.com such as Qwoter Featured Profiles, Qwoter Wire, Qwoter Press Blaster and Qwoter Boardroom Conferences. For a detailed service offering please go to the Qwoter.com website and see the Issuer Services section.